Utrogestan: Clinical Trials

4 trials of Utrogestan, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 4

Follow Utrogestan: new trials by email Literature Review of Utrogestan trials Research Report on Utrogestan

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Oral Dydrogesterone (OD) Versus Micronized Vaginal Progesterone (MVP) for Luteal Phase Support (LPS) in IVF/ICSI
Dydrogesterone Oral Tablet, Micronized progesterone, Placebo Dydrogesterone oral tablet - Infertility, Female, Infertility
Phase 4CompletedCRG UZ Brussel302019-05-012020-12-17
Vaginal Progesterone for the Prolongation of Pregnancy After Arrested Pre-term Labor
micronized progesterone 400 mg (Utrogestan) - Preterm Labor
Phase 4CompletedHaEmek Medical Center, Israel1292018-12-192023-02-28
Optimal Length of Progesterone Supplementation Before the Transfer of Cryopreserved (Frozen)-Thawed Day 3 Embryos in an Artificial Cycle With Exogenous Estrogen and Progesterone
Progesterone - Progesterone Supplementation
Phase 4CompletedUniversitair Ziekenhuis Brussel3002012-11-012019-09-27
Prophylactic Administration of Natural Progesterone in the Prevention of Preterm Delivery in Twin Pregnancies
progesterone, placebo - Preterm Delivery
Phase 4CompletedUniversity of Sao Paulo3902007-06-012014-12-04

Conditions studied

Genital Diseases, Female (1)  ·  Genital Diseases, Male (1)  ·  Infertility (1)  ·  Infertility, Female (1)  ·  Obstetric Labor, Premature (1)  ·  Premature Birth (1)

Sponsors

CRG UZ Brussel (1)  ·  HaEmek Medical Center, Israel (1)  ·  Universitair Ziekenhuis Brussel (1)  ·  University of Sao Paulo (1)

Countries

Belgium (2)  ·  Brazil (1)  ·  Israel (1)

Top investigators

Herman Tournaye, PhD, MD (1)  ·  Maria Brizot, PhD (1)

Results publications

PMID 27005893, PMID 38976270

NIH funding

2018 (1)